Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Clinical trial NCT04273061 · RECRUITING

Trial details

NCT number: NCT04273061
Sponsor: British Columbia Cancer Agency
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Lung Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Sarcoma Unknown Primary Tumors Head and Neck Cancer Skin Cancer

Start date: 2020-06-17
Primary completion: 2027-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.